Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

SMS-oncology Announces Changes to the Management Team

Published: Monday, February 04, 2013
Last Updated: Monday, February 04, 2013
Bookmark and Share
Specialized Medical Services-oncology BV announced its management team has been changed and expanded to five executive members.

Members are: Edwin Klumper (Chief Executive Officer, CEO), Philine van den Tol (Chief Operating Officer, COO), Eric van der Putten (Chief Business Development Officer, CBDO), Wouter Wijker (Managing Director Biometrics Unit), and Raymond Hoffmans (Director Consultancy).

The new CEO Edwin Klumper will succeed Eric van der Putten who will take on the position of CBDO. In his new role Eric will be responsible for driving new business opportunities and growing our client base. Edwin Klumper stated: "All credits go to Eric van der Putten who has been the driving force into building a fully GCP compliant CRO from scratch within five years that has resulted into ISO 9001:2008 certification in 2012. Our clients will benefit discussing their new cancer studies with Eric who brings to the table 30+ years of experience in running phase I and II cancer trials in close collaboration with the top tier of oncologists. His experience and operational insights will be of great value to our clients in achieving their objectives.”

Philine van den Tol has been promoted to the position of COO. With her no-nonsense and can-do attitude Philine motivates and leads by example the operational staff of SMS-oncology. She knows what it takes to run multiple multicenter cancer studies from her past experience as project manager for the Dutch Breast Cancer Trialists’ Group. The Management Team is completed by Raymond Hoffmans (Director Consultancy) and Wouter Wijker (Managing Director Biometrics Unit).

We thank Erik Leferink who has been leading in the foundation of SMS-oncology. Erik will hand over his business development responsibilities to Eric van der Putten. As a serial entrepreneur Erik will reallocate his time to grow new ventures that he has recently established. Erik will remain active as a shareholder of SMS-oncology.

“These changes reflect our steady growth and mark our next step”, said Edwin Klumper. “After 5 years of serving over 50 clients, building a highly motivated and oncology experienced staff, expanding our trial base across Europe, collaborating with top oncology centers, we are ready for our next step and ambition to become a European premier oncology CRO. It is a privilege to lead such a good team and serve our clients to jointly improve cancer treatment by developing new drugs that are desperately needed by so many patients".

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Biologists Induce Flatworms to Grow Heads and Brains of Other Species
Findings shed light on role of a new kind of epigenetic signaling in evolution, could yield clues for understanding birth defects and regeneration.
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos